The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of chemotherapy after treatment with regorafenib in metastatic colorectal cancer (mCRC).
 
Michael Todd Kidd
No Relationships to Disclose
 
Ryan Eldredge Wilcox
No Relationships to Disclose
 
Jane Rogers
No Relationships to Disclose
 
Cathy Eng
Honoraria - Roche; Sanofi
Consulting or Advisory Role - Bayer Schering Pharma; Roche/Genentech; Sanofi
Research Funding - ArQule; Keryx
Travel, Accommodations, Expenses - Genentech/Roche; Sanofi
 
Siamak Saadat
No Relationships to Disclose
 
Heinz-Josef Lenz
Leadership - Bayer
Honoraria - Bayer
Consulting or Advisory Role - Bayer
Research Funding - Bayer
Travel, Accommodations, Expenses - Bayer
 
Joleen Marie Hubbard
Consulting or Advisory Role - Bayer
Research Funding - Boston Biomedical (Inst); Genentech (Inst); PRISM Pharma (Inst)
 
Axel Grothey
Consulting or Advisory Role - Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Lilly (Inst)
Research Funding - Bayer (Inst); Eisai (Inst); Genentech (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - Bayer; Eisai; Genentech; Lilly